EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Study of fibromodulin gene expression in B-cell chronic lymphocytic leukemia

Doha Abd El-hamid Hassan, Rania Mohamed Samy, Osama Taha Abd-Elrahim, Caroline Sabry Salib

Journal of the Egyptian National Cancer Institute · 2011

DOI: 10.1016/j.jnci.2011.07.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Egyptian National Cancer Institute, 2011. Verfasst von Doha Abd El-hamid Hassan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt. Hauptthemen laut MEDLINE: Gene Expression. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND OBJECTIVES: It has become evident that fibromodulin and other members of the proteoglycan family are not only involved in collagen fibrillogenesis and cell adhesion but they also contribute to modulation of cytokine activity, suppression of tumor growth, and prevention of apoptosis. Fibromodulin has been characterized as one of the tumor associated antigens (TAA) in B cell chronic lymphocytic leukemia (B-CLL) with the potential to elicit specific antitumor response and it is considered as good candidate for immunotherapy. AIM OF WORK: to study the expression of fibromodulin at the gene level of B-cell chronic lymphocytic leukemia patients, in comparison to normal controls and to asses its role in the pathophysiology of CLL. PATIENTS AND METHODS: Fibromodulin gene expression was tested by one step reverse transcription-polymerase chain reaction (RT-PCR) in peripheral blood mononuclear cells of 30 patients with B-CLL as well as in 20 age and sex matched healthy volunteers. RESULTS: In this study, fibromodulin gene was expressed in 46.7% of patients with B-CLL which was significantly different from the control age and sex matched healthy volunteers in which none of them showed peripheral blood mononuclear cells positivity for fibromodulin gene expression (0%) (p-value =0.006). We also found significant associations between higher fibomodulin gene expression and some risk factors in the studied CLL cases such as hepatomegaly, lower haemoglobin level, lower RBCs count, lower platelet count and borderline significant associations with other risk factors as lymphadenopathy and splenomegaly. CONCLUSION: Our results suggest that fibromodulin can be used as a target for therapeutic intervention and it may play a role in the pathophysiology of CLL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene ExpressionAdultAgedCase-Control StudiesExtracellular Matrix ProteinsFemaleFibromodulinHepatomegalyHumansLeukemia, Lymphocytic, Chronic, B-CellLymphatic DiseasesMaleMiddle AgedProteoglycansRNA, MessengerReverse Transcriptase Polymerase Chain ReactionRisk FactorsSplenomegaly

Substanzen

Extracellular Matrix ProteinsFMOD protein, humanProteoglycansRNA, MessengerFibromodulin

Autor:innen und Institutionen

  • Department of Clinical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt.

Zitieren

APA

Hassan, D. A., Samy, R. M., Abd-Elrahim, O. T., & Salib, C. S. (2011). Study of fibromodulin gene expression in B-cell chronic lymphocytic leukemia. Journal of the Egyptian National Cancer Institute. https://doi.org/10.1016/j.jnci.2011.07.002

Vancouver

Hassan DA, Samy RM, Abd-Elrahim OT, Salib CS. Study of fibromodulin gene expression in B-cell chronic lymphocytic leukemia. Journal of the Egyptian National Cancer Institute. 2011. doi:10.1016/j.jnci.2011.07.002

BibTeX
@article{Hassan2011,
  author = {Hassan, Doha Abd El-hamid and Samy, Rania Mohamed and Abd-Elrahim, Osama Taha and Salib, Caroline Sabry},
  title = {Study of fibromodulin gene expression in B-cell chronic lymphocytic leukemia},
  journal = {Journal of the Egyptian National Cancer Institute},
  year = {2011},
  doi = {10.1016/j.jnci.2011.07.002}
}
Kostenlos starten →